Logo image of BRKRP

BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) Stock Fundamental Analysis

USA - NASDAQ:BRKRP - US1167942077

321.62 USD
+0.27 (+0.08%)
Last: 11/5/2025, 8:00:02 PM
Fundamental Rating

4

BRKRP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While BRKRP is still in line with the averages on profitability rating, there are concerns on its financial health. BRKRP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BRKRP had positive earnings in the past year.
BRKRP had a positive operating cash flow in the past year.
BRKRP had positive earnings in each of the past 5 years.
Each year in the past 5 years BRKRP had a positive operating cash flow.
BRKRP Yearly Net Income VS EBIT VS OCF VS FCFBRKRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

BRKRP has a better Return On Assets (1.26%) than 68.97% of its industry peers.
The Return On Equity of BRKRP (4.41%) is better than 72.41% of its industry peers.
BRKRP has a Return On Invested Capital of 4.48%. This is in the better half of the industry: BRKRP outperforms 67.24% of its industry peers.
BRKRP had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 13.50%.
The 3 year average ROIC (9.30%) for BRKRP is well above the current ROIC(4.48%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.26%
ROE 4.41%
ROIC 4.48%
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
BRKRP Yearly ROA, ROE, ROICBRKRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BRKRP has a Profit Margin of 2.31%. This is in the better half of the industry: BRKRP outperforms 68.97% of its industry peers.
BRKRP's Profit Margin has declined in the last couple of years.
The Operating Margin of BRKRP (9.69%) is better than 65.52% of its industry peers.
BRKRP's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 48.54%, BRKRP is in line with its industry, outperforming 50.00% of the companies in the same industry.
BRKRP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.69%
PM (TTM) 2.31%
GM 48.54%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
BRKRP Yearly Profit, Operating, Gross MarginsBRKRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKRP is destroying value.
BRKRP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRKRP has less shares outstanding
Compared to 1 year ago, BRKRP has a worse debt to assets ratio.
BRKRP Yearly Shares OutstandingBRKRP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BRKRP Yearly Total Debt VS Total AssetsBRKRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 7.85 indicates that BRKRP is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.85, BRKRP belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
BRKRP has a debt to FCF ratio of 49.40. This is a negative value and a sign of low solvency as BRKRP would need 49.40 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 49.40, BRKRP is in line with its industry, outperforming 48.28% of the companies in the same industry.
A Debt/Equity ratio of 1.32 is on the high side and indicates that BRKRP has dependencies on debt financing.
The Debt to Equity ratio of BRKRP (1.32) is worse than 81.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 49.4
Altman-Z 7.85
ROIC/WACC0.43
WACC10.39%
BRKRP Yearly LT Debt VS Equity VS FCFBRKRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.61 indicates that BRKRP should not have too much problems paying its short term obligations.
BRKRP's Current ratio of 1.61 is on the low side compared to the rest of the industry. BRKRP is outperformed by 67.24% of its industry peers.
A Quick Ratio of 0.68 indicates that BRKRP may have some problems paying its short term obligations.
BRKRP has a worse Quick ratio (0.68) than 91.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.68
BRKRP Yearly Current Assets VS Current LiabilitesBRKRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The earnings per share for BRKRP have decreased strongly by -18.37% in the last year.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
BRKRP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.56%.
Measured over the past years, BRKRP shows a quite strong growth in Revenue. The Revenue has been growing by 10.19% on average per year.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)13.56%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%

3.2 Future

Based on estimates for the next years, BRKRP will show a small growth in Earnings Per Share. The EPS will grow by 4.89% on average per year.
The Revenue is expected to grow by 2.65% on average over the next years.
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRKRP Yearly Revenue VS EstimatesBRKRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
BRKRP Yearly EPS VS EstimatesBRKRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 160.81 indicates a quite expensive valuation of BRKRP.
The rest of the industry has a similar Price/Earnings ratio as BRKRP.
The average S&P500 Price/Earnings ratio is at 26.13. BRKRP is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 139.32, the valuation of BRKRP can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as BRKRP.
BRKRP is valuated expensively when we compare the Price/Forward Earnings ratio to 22.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 160.81
Fwd PE 139.32
BRKRP Price Earnings VS Forward Price EarningsBRKRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRKRP.
BRKRP's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 989.78
EV/EBITDA 93.93
BRKRP Per share dataBRKRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

BRKRP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)17.97
EPS Next 2Y-2.13%
EPS Next 3Y4.74%

3

5. Dividend

5.1 Amount

BRKRP has a yearly dividend return of 0.50%, which is pretty low.
BRKRP's Dividend Yield is rather good when compared to the industry average which is at 0.49. BRKRP pays more dividend than 91.38% of the companies in the same industry.
With a Dividend Yield of 0.50, BRKRP pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

The dividend of BRKRP has a limited annual growth rate of 4.81%.
BRKRP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

38.32% of the earnings are spent on dividend by BRKRP. This is a low number and sustainable payout ratio.
The dividend of BRKRP is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP38.32%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
BRKRP Yearly Income VS Free CF VS DividendBRKRP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BRKRP Dividend Payout.BRKRP Dividend Payout, showing the Payout Ratio.BRKRP Dividend Payout.PayoutRetained Earnings

BRUKER CORP - BRKR 6 3/8 09/01/28

NASDAQ:BRKRP (11/5/2025, 8:00:02 PM)

321.62

+0.27 (+0.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners84.43%
Inst Owner ChangeN/A
Ins Owners26.98%
Ins Owner ChangeN/A
Market Cap48.80B
Revenue(TTM)3.37B
Net Income(TTM)79.60M
Analysts76.19
Price Target362.61 (12.74%)
Short Float %0%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.29%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 160.81
Fwd PE 139.32
P/S 14.17
P/FCF 989.78
P/OCF 294.13
P/B 27.05
P/tB N/A
EV/EBITDA 93.93
EPS(TTM)2
EY0.62%
EPS(NY)2.31
Fwd EY0.72%
FCF(TTM)0.32
FCFY0.1%
OCF(TTM)1.09
OCFY0.34%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)17.97
Graham Number23.13
Profitability
Industry RankSector Rank
ROA 1.26%
ROE 4.41%
ROCE 6.68%
ROIC 4.48%
ROICexc 4.57%
ROICexgc 9.81%
OM 9.69%
PM (TTM) 2.31%
GM 48.54%
FCFM 1.43%
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 49.4
Debt/EBITDA 4.37
Cap/Depr 55.42%
Cap/Sales 3.39%
Interest Coverage 250
Cash Conversion 30.5%
Profit Quality 61.93%
Current Ratio 1.61
Quick Ratio 0.68
Altman-Z 7.85
F-Score5
WACC10.39%
ROIC/WACC0.43
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-17.24%
EPS Next 2Y-2.13%
EPS Next 3Y4.74%
EPS Next 5Y4.89%
Revenue 1Y (TTM)13.56%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year2.6%
Revenue Next 2Y1.97%
Revenue Next 3Y3.23%
Revenue Next 5Y2.65%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y9.46%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%

BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP FAQ

What is the fundamental rating for BRKRP stock?

ChartMill assigns a fundamental rating of 4 / 10 to BRKRP.


Can you provide the valuation status for BRUKER CORP - BRKR 6 3/8 09/01/28?

ChartMill assigns a valuation rating of 2 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.


Can you provide the profitability details for BRUKER CORP - BRKR 6 3/8 09/01/28?

BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 6 / 10.


What is the valuation of BRUKER CORP - BRKR 6 3/8 09/01/28 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 160.81 and the Price/Book (PB) ratio is 27.05.


Can you provide the expected EPS growth for BRKRP stock?

The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to decline by -17.24% in the next year.